Cargando…
Managing hypertension during the COVID-19 pandemic
Autores principales: | Nadar, Sunil K., Tayebjee, Muzahir H., Stowasser, Michael, Byrd, James Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224587/ https://www.ncbi.nlm.nih.gov/pubmed/32409727 http://dx.doi.org/10.1038/s41371-020-0356-y |
Ejemplares similares
-
Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Bonny, Aimé, et al.
Publicado: (2020) -
Aldosterone, gut microbiome and hypertension: selected papers from APCH 2019
por: Stowasser, Michael
Publicado: (2021) -
Managing drug-induced QT prolongation in clinical practice
por: Khatib, Rani, et al.
Publicado: (2021) -
Empirical anticoagulation for patients in sinus rhythm at high risk of ischaemic stroke: A review of current literature
por: Battipaglia, Irma, et al.
Publicado: (2017) -
Coronary Guidewires in Temporary Cardiac Pacing and Assessment of Myocardial Viability: Current Perspectives and Future Directions
por: Javid, Rabeia, et al.
Publicado: (2023)